SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-082281
Filing Date
2024-09-26
Accepted
2024-09-26 16:40:41
Documents
128
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0215061-20f_alterity.htm   iXBRL 20-F 2320637
2 RIGHTS ATTACHED TO ORDINARY SHARES ea021506101ex2-3_alterity.htm EX-2.3 7463
3 LIST OF SUBSIDIARIES OF THE REGISTRANT ea021506101ex8-1_alterity.htm EX-8.1 1352
4 SECURITIES TRADING POLICY ea021506101ex11-1_alterity.htm EX-11.1 100011
5 CERTIFICATION ea021506101ex12-1_alterity.htm EX-12.1 10950
6 CERTIFICATION ea021506101ex12-2_alterity.htm EX-12.2 11177
7 CERTIFICATION ea021506101ex13-1_alterity.htm EX-13.1 3700
8 CERTIFICATION ea021506101ex13-2_alterity.htm EX-13.2 3749
9 CONSENT OF PRICEWATERHOUSECOOPERS ea021506101ex15-1_alterity.htm EX-15.1 1580
10 AUDITORS INDEPENDENCE DECLARATION ea021506101ex15-2_alterity.htm EX-15.2 1700
11 INCENTIVE-BASED COMPENSATION RECOVERY POLICY EFFECTIVE NOVEMBER 1, 2023 ea021506101ex97-1_alterity.htm EX-97.1 27106
12 GRAPHIC image_001.jpg GRAPHIC 70534
13 GRAPHIC ex11-1_001.jpg GRAPHIC 5663
14 GRAPHIC ex97-1_001.jpg GRAPHIC 4331
  Complete submission text file 0001213900-24-082281.txt   10829804

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE athe-20240630.xsd EX-101.SCH 137805
16 XBRL CALCULATION FILE athe-20240630_cal.xml EX-101.CAL 49390
17 XBRL DEFINITION FILE athe-20240630_def.xml EX-101.DEF 399840
18 XBRL LABEL FILE athe-20240630_lab.xml EX-101.LAB 805843
19 XBRL PRESENTATION FILE athe-20240630_pre.xml EX-101.PRE 423585
131 EXTRACTED XBRL INSTANCE DOCUMENT ea0215061-20f_alterity_htm.xml XML 1941600
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-49843 | Film No.: 241329497
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)